Katherine Ruzhansky to Humans
This is a "connection" page, showing publications Katherine Ruzhansky has written about Humans.
Connection Strength
0.083
-
Neuromuscular complications of hematopoietic stem cell transplantation. Muscle Nerve. 2015 Oct; 52(4):480-7.
Score: 0.020
-
Discordant phenotype in monozygotic female twins with Lys35Thr TTR familial amyloidotic polyneuropathy. J Clin Neuromuscul Dis. 2014 Sep; 16(1):1-6.
Score: 0.019
-
The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events. PLoS One. 2022; 17(2):e0262109.
Score: 0.008
-
Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE). Muscle Nerve. 2021 09; 64(3):270-276.
Score: 0.008
-
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis. Muscle Nerve. 2019 04; 59(4):404-410.
Score: 0.006
-
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review. Neurology. 2017 Sep 05; 89(10):1069-1077.
Score: 0.006
-
Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial. Muscle Nerve. 2017 Nov; 56(5):901-911.
Score: 0.006
-
Causes of neuropathy in patients referred as "idiopathic neuropathy". Muscle Nerve. 2016 06; 53(6):856-61.
Score: 0.005
-
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine. Muscle Nerve. 2016 Feb; 53(2):165-8.
Score: 0.005